Abstract: Systems and methods to simulate activity that would be recorded using an interface to nerve fibers are provided. Signals, such as motor intent signals, can be converted to neural recordings, such as neural recordings by longitudinal intrafascicular electrodes (LIFEs). Spinal cord motor pools and neural interfaces can be jointly simulated. Realistic simulated neural recordings, such as from electrodes such as LIFEs, can be provided and can be used for the evaluation of decoding algorithms. Systems and methods described herein provide a framework for developing neural interface devices.
Type:
Grant
Filed:
October 16, 2013
Date of Patent:
February 7, 2017
Assignee:
The Florida International University Board of Trustees
Inventors:
Mohamed Abdelghani, Ranu Jung, James J. Abbas, Kenneth Horch
Abstract: An object of the present invention is to provide a novel endoparasite control agent as a parasiticide, an antiprotozoal or the like. Provided is an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): (wherein Het represents a 5- or 6-membered heterocyclic group), or a salt thereof as an active ingredient.
Type:
Grant
Filed:
August 29, 2013
Date of Patent:
February 7, 2017
Assignees:
The University of Tokyo, Nihon Nohyaku Co., Ltd.
Inventors:
Kiyoshi Kita, Akiyuki Suwa, Masatsugu Oda, Koji Tanaka
Abstract: The present invention relates to novel series of amine-containing flavonoids and compositions containing the compounds, as well as the synthesis and the use of the same. The invention also relates to methods of treatment and prevention of diseases, in particular, parasitic infections including Leishmaniasis, comprising administration of the compounds.
Type:
Grant
Filed:
February 26, 2015
Date of Patent:
February 7, 2017
Assignee:
The Hong Kong Polytechnic University
Inventors:
Larry Ming-Cheung Chow, William Tak Hang Chan, Kin-Fai Chan, Iris Lai King Wong, Wing-Yiu Kan
Abstract: A noninvasive remote parameter sensor and sensing method is provided that is particularly suited for the remote monitoring of skin temperature. The sensor and sensing method utilize luminescence-based sensors that are non-toxic and non-irritating to the skin. The sensor preferably utilizes one or more types of fluorophores that are embedded in a soft hydrogel. The sensor is illuminated with excitation light, and temperature is monitored by detecting and analyzing the emission light from the fluorophores. Because a soft hydrogel is used, the sensor can be gently wiped off the skin at the conclusion of temperature measurements.
Type:
Grant
Filed:
June 29, 2012
Date of Patent:
February 7, 2017
Assignee:
University of Maryland Baltimore County
Inventors:
Leah Tolosa, Hung Lam, Yordan Kostov, Steven M Falk, Govind Rao
Abstract: The invention provides compounds of formula I: wherein A, B, X, and Y have any of the values defined in the specification, as well as pharmaceutical compositions comprising such compounds, processes for preparing such compounds, and therapeutic methods for treating cancer and other topoisomerase mediated conditions.
Type:
Grant
Filed:
March 5, 2010
Date of Patent:
February 7, 2017
Assignee:
Rutgers, the State University of New Jersey
Inventors:
Edmond J. LaVoie, Wei Feng, Leroy F. Liu
Abstract: The invention is directed to non-invasive methods of detecting gastric cancer in an individual in need thereof comprising determining an expression level of inter-alpha-trypsin inhibitor heavy chain H3 (ITIH3) in the individual and comparing the expression level to a control, wherein an increase in the expression level of ITIH3 in the individual compared to the control is indicative of gastric cancer in the individual.
Abstract: A process for the preparation from a partially decomposed organic material like peat a granulated or pelletized sorption medium using low-temperature, thermal activation of the sorption medium to produce a high degree of granule or pellet hardness balanced against an efficacious level of ion-exchange and adsorption capacity, followed by chemical treatment of the thermally-activated sorption material via an acid solution and a salt solution to increase its ion-exchange and adsorption performance while minimizing the transfer of natural impurities found in the sorption medium to an aqueous solution is provided by this invention. The sorption medium of this invention can be used in a variety of aqueous solution treatment processes, such as wastewater treatment.
Type:
Grant
Filed:
March 14, 2014
Date of Patent:
February 7, 2017
Assignees:
American Peat Technology, LLC, Reagents of the University of Minnesota
Inventors:
Igor V. Kolomitsyn, Peggy Wallgren Jones, Douglas A. Green
Abstract: The disclosure relates to a technical field of deep hole machining, particularly to a deep hole machining on-line deviating correction device based on laser detection, which solves the prior art problem of difficulty in the real-time, on-line detection and deviating correction in the process of deep hole machining. The device comprises a deep hole cutter and a cutter bar, and arranged on the cutter bar are a laser orientating block, a pyramid prism seat, the deep hole cutter and a metallic block with a heating device arranged therein. A beam emitted by a laser transmitter is orientated by the laser orientating block so as to be incident in parallel with the axis of the cutter bar, and then through a pyramid prism to form a return beam which reaches the photosensitive sensor.
Abstract: A biocompatible composition for tissue repair or regeneration in mammals comprising one or more glass former compounds selected from the group consisting of B2O3, P2O5, and SiO2 and director elements selected from the group consisting of Cu, Sr, Zn, Fe, Mn, Cr, V, Nb, Mo, W, Ba, Co, S, Al, Ti, Y, Mg, Si and/or Ni to promote in vivo calcium compound formation of calcium carbonate or other calcium compounds other than hydroxyapatite. Upon direct application of the biocompatible composition to a mammalian host, calcium carbonate or other calcium compounds other than hydroxyapatite form upon bioreaction of the composition with bodily fluids.
Type:
Grant
Filed:
July 6, 2012
Date of Patent:
February 7, 2017
Assignee:
The Curators of the University of Missouri
Abstract: A method for making a composite carbon nanotube structure is introduced. The method includes the following steps. A carbon nanotube structure and a polymer are provided. The polymer and the carbon nanotube structure are composited together. The composite carbon nanotube structure composited with polymer and the carbon nanotube is then graphitized.
Type:
Grant
Filed:
August 27, 2015
Date of Patent:
February 7, 2017
Assignees:
Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.
Inventors:
Kai Liu, Kai-Li Jiang, Ying-Hui Sun, Shou-Shan Fan
Abstract: Provided herein are primers comprising a nucleotide sequence complementary to a portion of a RhD gene. Also provided herein are methods of determining a RhD zygosity in a subject. Also provided are methods of detecting a weak D allele in a subject. Further provided are kits for determining an RhD zygosity.
Abstract: Disclosed are nanoparticle compositions comprising nanoparticles prepared from denatured, cross-linked albumin and a therapeutic agent for treating a neutrophil-mediated inflammation, and methods of treating neutrophil-mediated inflammation using the compositions.
Type:
Grant
Filed:
June 26, 2014
Date of Patent:
February 7, 2017
Assignee:
The Board of Trustees of the University of Illinois
Inventors:
Zhenjia Wang, Jaehyung Cho, Asrar Malik
Abstract: With example embodiments described herein, a probe tip of a scanning probe microscope (such as an atomic force microscope (AFM)) is directly detected as it moves in a tapping mode to determine the tip positions over time, and a force for the tip is computed from these determined tip positions.
Type:
Grant
Filed:
October 1, 2015
Date of Patent:
February 7, 2017
Assignee:
The Curators of the University of Missouri
Abstract: A reactor includes a reactor chamber and a carbon nanotube catalyst composite layer. The reactor chamber has an inlet and an outlet. The carbon nanotube catalyst composite layer is suspended in the reactor chamber, wherein the carbon nanotube catalyst composite layer defines a number of apertures, gases in the reactor chamber penetrate the carbon nanotube catalyst composite layer through the plurality of apertures.
Type:
Grant
Filed:
April 25, 2013
Date of Patent:
February 7, 2017
Assignees:
Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.
Inventors:
Yang Wu, Peng Liu, Yang Wei, Jia-Ping Wang, Kai-Li Jiang, Shou-Shan Fan
Abstract: In one aspect of the invention, an ion trap mass analyzer includes a variable- or multi-potential type ion guide (MPIG) assembly which has been pre-configured to produce a parabolic-type potential field. Each MPIG electrode has a resistive coating of designed characteristics. In one example the coating varies in thickness along the length of an underlying uniform substrate. The MPIG assembly can be a single MPIG electrode or an array of a plurality of MPIG electrodes. An array can facilitate delocalization for improved performance. This chemical modification of a uniform underlying substrate promotes cheaper and flexible instruments. The modified MPIG electrodes also allow miniaturization (e.g. micro and perhaps even nano-scale), which allows miniaturization of the instrument in which the single or plural modified MPIG electrode(s) are placed. This promotes portability and field use instead of limitation to laboratory settings.
Type:
Grant
Filed:
October 14, 2015
Date of Patent:
February 7, 2017
Assignee:
University of Northern Iowa Research Foundation
Abstract: The present invention provides an immunoconjugate having the formula: T-c-En-c-Fcn or T-c-Fcn-c-En; wherein, T is a single chain variable portion fragment of a monoclonal antibody (scFv) directed to a target protein, polypeptide, or fragment thereof, which is highly expressed on cancer cells; E is two or more foreign immunogenic CD8+ T cell antigenic epitopes; c is a peptide or polypeptide fragment thereof, capable of being cleaved by a specific protease; and Fc is two or more Fc portions of an IgG antibody. Nucleic acid sequences encoding the same and vectors containing said nucleic acid sequences are also provided. Methods of making the immunoconjugate, along with methods of making target cells susceptible to CTL mediated cell killing, and methods for treatment of cancers are also provided.
Abstract: A template-free reverse micelle (RM) based method is used to synthesize pyrochlore nanostructures having photocatalytic activity. In one embodiment, the method includes separately mixing together a first acid stabilized aqueous solution including pyrochlore precursor A and a second acid stabilized aqueous solution including pyrochlore precursor B with an organic solution including a surfactant to form an oil-in-water emulsion. Next, equimolar solutions of the first and second acid stabilized oil-in-water emulsions are mixed together. Then, the mixture of the first and second acid stabilized oil-in-water emulsion is treated with a base to produce a precipitate including pyrochlore precursors A and B. After which, the precipitate is dried to remove volatiles. The precipitate is then calcined in the presence of oxygen to form a pyrochlore nanostructure, such as a bismuth titanate (Bi2Ti2O7) pyrochlore nanorod. The method of synthesizing the pyrochlore nanorod is template-free.
Type:
Grant
Filed:
November 24, 2014
Date of Patent:
February 7, 2017
Assignee:
Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno
Abstract: A method of fabricating a transient semiconductor based on a single-wall nanotube includes stacking a thermal oxide layer on a silicon substrate and depositing a nickel thin layer on the thermal oxide layer, depositing an oxide layer on the nickel thin layer, depositing a metallic layer on the oxide layer, and patterning the metallic layer to form a gate electrode, depositing a gate insulating layer on the gate electrode, changing a surface of the gate insulating layer into a hydrophilic surface, and washing and drying the gate insulting layer, coating a single-wall nanotube on the hydrophilic surface of the gate insulating layer, forming source and drain electrodes by forming a contact opening with respect to the gate insulating layer, attaching a thermal release tape after removing a surrounding single-wall nanotube, performing a transfer onto a polyvinyl alcohol thin layer after etching the nickel thin layer, and releasing the thermal release.
Type:
Grant
Filed:
May 11, 2016
Date of Patent:
February 7, 2017
Assignee:
Incheon University Industry Academic Cooperation Foundation
Abstract: The present invention provides methods and materials for treating and preventing autoimmune diseases. In particular, the present invention relates to the discovery that small peptides are capable of interacting with CD40, thereby interfering with the ability of CD40 to interact with CD 154, which is important in inflammation. The present invention also relate to the use of such peptides in reducing the inflammatory response, and in particular, the autoimmune inflammatory response. The present invention also relates to the use of such short peptides to prevent or reverse autoimmune disease, and particular, diabetes, in individuals suffering from such disease. It also relates to methods and materials for detecting T-cells that express CD40 (Th40 cells). Also provided are kits for reducing inflammation, treating autoimmune diseases, or detecting Th40 cells.
Type:
Grant
Filed:
October 19, 2011
Date of Patent:
February 7, 2017
Assignee:
The Regents of the University of Colorado, a body corporate
Abstract: Production of products by engineered bacteria is increased by regulating cellular respiration. Cellular respiration is controlled by reducing electron transfer enzyme activity. Some examples of electron transfer enzymes include NADH dehydrogenases, Succinate dehydrogenases, ubiquinone synthesis, cytochrome O, and cytochrome D. In one example, deletion of UbiCA prevents respiration. Respiration can the be controlled by addition of ubiquinone or expression of ubiCA.